Expression of Ki67 as a Prognostic Marker in Invasive Breast Carcinoma

Journal Title: National Journal of Laboratory Medicine - Year 2017, Vol 6, Issue 3

Abstract

Introduction: Breast cancer is the most common cancer in women of developed countries. It accounts for 16% and 22.9% of cancers and invasive cancers, respectively. About 18.2% of deaths related to cancer amongst men and women have been attributed to breast cancer. Every year, more than 10,000 incipient breast cancer patients reckon to be diagnosed in India. Aim: To evaluate the role of Ki67 as a predictive biomarker in invasive breast cancer patients and to study its correlation with various molecular subtypes of breast cancer. Materials and Methods: A cross-sectional and descriptive study, of 100 cases of breast carcinoma coming to Histopathology section in Department of Pathology, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Dehradun, India, was carried out over a period of one year, from 2013 to 2014. Patients were randomly selected for the study. Results: Sixty nine patients showed high proliferating index of Ki67 (>30%), followed by 20% patients that showed low proliferating index (≤15%) and 11% patients showed intermediate proliferating index (16-30%). Maximum patients were of Luminal A subtype, of which 50% showed high proliferating index. In the Luminal B subtype, 64% patients showed high proliferating index and in the Her-2 subtype, 73.9% showed high proliferating index. Of Triple Negative Breast Cancer (TNBC) subtype 86.3% showed high proliferating index. Majority of patients were of IDC (n=94). Out of these, 64(68%) patients showed high proliferating index for Ki67 immunostaining. Out of 5 patients of ILC, 3 (60%) showed high proliferating index for Ki67 immunostaining. One case of mucinous carcinoma showed low proliferating index for Ki67 immunostaining. Conclusion: High proliferating index tumours were mostly large in size. We could not find any correlation with various molecular subtypes of breast carcinoma. Though, not statistically significant, we observed that TNBC were most aggressive and showed highest rate of proliferation and Ki67 expression. High levels of Ki67 were associated with TNBC, Her2/neu and Luminal B while low and medium levels with Luminal A subtype. Ki67 immunostaining can be used as an important biomarker for proliferation.

Authors and Affiliations

Dr. Rashi Ahuja, Dr. Neena Chauhan, Dr. Sunil Saini, Dr. Meena Harsh

Keywords

Related Articles

Amoebic Liver Abscess: A Complete Overview in Tertiary Care Centre

Introduction: Amoebiasis is defined as human infection with protozoan parasite, Entamoeba histolytica regardless of the clinical outcome. It commonly resides in large intestine but can invade to other organs. Amoebic Liv...

Squash Smear Cytology, CNS Lesions – Strengths and Limitations

Introduction: Cytodiagnosis of CNS Space Occupying Lesions (SOLs) by squash smear preparation is a rapid, inexpensive and fairly accurate diagnostic tool. Most of the studies till date have proved its utility in intraope...

An Unusual Case of Perforation Peritonitis: A Diagnostic DilemmaBacterial or Parasitic?

Large intestinal perforation due to mixed parasitic and bacterial aetiology is a rare entity. We report the case of a 63 years old man, who underwent a therapeutic paracentesis for ascites, which revealed eggs of hookwor...

Resistant Microorganisms Isolated from Cases of Chronic Suppurative Otitis Media: A Therapeutic Concern

Introduction: Chronic Suppurative Otitis Media (CSOM) still is a common health care problem in developing countries like India with its potential for serious local damage and complications. Knowledge of causative microor...

Application of Probabilistic Approach in Reporting Breast Lesions on Fine Needle Aspiration Cytology: Institutional Study

Introduction: Cancer of breast is among the most common cancer throughout the world. In Indian women rising incidence of breast cancer remains a concern. Due to lack of health awareness and limited breast cancer screenin...

Download PDF file
  • EP ID EP377206
  • DOI 10.7860/NJLM/2017/25293:2237
  • Views 108
  • Downloads 0

How To Cite

Dr. Rashi Ahuja, Dr. Neena Chauhan, Dr. Sunil Saini, Dr. Meena Harsh (2017). Expression of Ki67 as a Prognostic Marker in Invasive Breast Carcinoma. National Journal of Laboratory Medicine, 6(3), 6-12. https://europub.co.uk/articles/-A-377206